AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Dyadic Personalized Home-Based Activity Program for Mild-to-Moderate Dementia Patients Post-Discharge

RecruitingNAAges 60 Years - anyAllFujian Medical University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This interventional study aims to evaluate the efficacy of a dyadic personalized home-based activity program in managing behavioral and psychological symptoms of dementia (BPSD) among home-dwelling people living with mild-to-moderate dementia post-discharge. The main question it aims to answer is: Does the dyadic personalized home-based activity program significantly reduce BPSD in individuals post-discharge with mild-to-moderate dementia? Researchers will compare individuals living with mild to moderate dementia who are receiving routine care to see if the dyadic personalized home-based activity program is effective for BPSD. Participants will: 1. In-hospital stage: A personalized home-based activity intervention plan is tailored for patients. Family caregivers receive professional training on care skills related to home-based activities and are provided with corresponding activity

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria Patients * Be aged โ‰ฅ 60 years; * Have a diagnosis of dementia according to ICD-10 criteria, with a Clinical Dementia Rating (CDR) score of 1-2 (mild-to-moderate stage); * Retain basic verbal communication ability; * Present at least one neuropsychiatric symptom (a score โ‰ฅ 1 on any single item) within the past month, as evaluated by the Neuropsychiatric Inventory (NPI); * Be medically fit for hospital discharge and scheduled to receive home care post-discharge; * Be willing to participate in this study and provide written informed consent. Family Caregivers * Be aged โ‰ฅ 18 years; * Have kinship with the patient (e.g., spouse, children, siblings, etc.); * Undertake primary care responsibilities on an unpaid, non-professional basis, and have the longest average daily care hours among all family caregivers; * Be willing to assume continuous home care responsibilities for at least 3 months post-discharge; * Have intact verbal communication skills; * Possess basic proficiency in operating the WeChat application (a widely used social communication application in China), including independently sending and receiving messages, as well as making voice and video calls๏ผ› * Be willing to participate in this study and provide written informed consent. Exclusion Criteria Patients * Have severe somatic diseases (e.g., malignant tumors, heart failure, physical disabilities) or severe psychiatric disorders; * Have severe visual or hearing impairment; * Have dementia secondary to the following conditions: central nervous system diseases (e.g., encephalitis, brain tumors, epilepsy, multiple sclerosis, Parkinson's disease), nutritional and metabolic disorders (e.g., thyroid dysfunction, vitamin B12 or folate deficiency), substance or alcohol dependence, and other potential causes of secondary dementia; * Suffer from severe physical or mental disorders, extreme debilitation, long-term bedridden status, end-stage disease with a life expectancy of less than six months, or be unable to cooperate with or tolerate the study intervention; * Be enrolled in any other clinical research that may interfere with the outcomes of this study. Family Caregivers * Have severe somatic diseases (e.g., malignant tumors, heart failure, physical disabilities) or severe psychiatric disorders; * Have severe visual or hearing impairment; * Be enrolled in any other clinical research that may interfere with the outcomes of this study.
๐Ÿ’Š

What it tests

  • Dyadic personalized home-based activity program intervention
  • Routine care
๐Ÿ“

Where

1 site
Union Hospital Affiliated to Fujian Medical University
Fujian, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy